Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF]

Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF]

The Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF] is a cutting-edge research tool designed for the study of Topo Ⅱ, an essential enzyme in cellular processes. This antibody offers a highly specific and reliable method for detecting and analyzing Topo Ⅱ expression in various tissues and cell lines. With its mouse host and human reactivity, the Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF] is a powerful tool for researchers in the fields of oncology, pharmacology, and cellular biology. Key features include its high affinity for human Topo Ⅱ, compatibility with IHC-P applications, and its ability to localize within the nucleus.

• High specificity for human Topo Ⅱ
• Applications in IHC-P
• Cellular localization in the nucleus

Product Details

The Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF] is produced using mouse immunization, ensuring a robust and reliable response. It is designed to react with human Topo Ⅱ, making it ideal for studies focused on human cellular processes. This antibody is suitable for use in IHC-P, providing clear and consistent results. The antibody is also tissue-specific, with high expression levels observed in the tonsil, making it a valuable tool for studying this tissue. Technical specifications include:

Host: Mouse

Reactivity: Human

Applications: IHC-P

Cellular Localization: Nucleus

Tissue Specificity: Tonsil

Applications and Benefits

The Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF] is a versatile tool with a wide range of applications in research. Its high specificity and tissue specificity make it particularly useful for studying drug resistance in tumors, as well as for understanding the role of Topo Ⅱ in cell proliferation and apoptosis. This antibody is also suitable for use in clinical diagnostics, where it can help identify patients who may respond well to certain tumor drugs. Benefits of using the Certified Safe Topo2a Monoclonal Antibody Unlock 80% Savings [VdCTnXgF] include:

Enhanced understanding of tumor drug resistance

Improved diagnosis and treatment of tumors

Contribution to advancements in oncology and pharmacology research